SRIPRASIT GROUP is a prominent pharmaceutical importer and distributor based in Thailand, with a rich history dating back to 1949. Originally focused on generic products, the company expanded its operations significantly in 1975 by venturing into manufacturing through Sriprasit Pharma Co., Ltd. Their modern production facility, established in 2012 in Samutsakhon, adheres to stringent quality standards with both GMP certification from the Thai FDA and international recognition from the Malaysian Ministry of Health.

SRIPRASIT GROUP specializes in a variety of therapeutic areas, including Cardiovascular, Respiratory, Rheumatology, Metabolism, Neuro-muscular, Dermatological, and Gastrointestinal health. The company serves both the Ethical market, which includes public and private medical institutions, and the OTC market, covering a wide range of drug stores. Their robust distribution network is bolstered by international partnerships, fostering the development and availability of generic products across Thailand and beyond. With decades of experience, SRIPRASIT GROUP remains dedicated to enhancing health outcomes through accessible pharmaceutical solutions.